Cederbrant K, Stejskal V, Broman P, Lindkvist L, Sundell K
Safety Assessment, Astra AB, Södertälje, Sweden.
Allergy. 1998 Dec;53(12):1155-61. doi: 10.1111/j.1398-9995.1998.tb03835.x.
The aim of this study was to investigate in vitro lymphocyte proliferation in the diagnosis of allergy to phenoxymethylpenicillin (PcV), comparing chemically reactive PcV, added to cell cultures in unconjugated form, to a PcV-PLL (poly-L-lysine) conjugate as antigens. Side-chain specificity of lymphoproliferative responses was investigated with reactive benzylpenicillin (PcG) and bacampicillin.
Seventeen patients with a history of hypersensitivity reactions in connection with PcV treatment were studied by means of the lymphocyte transformation test (LTT), the radioallergosorbent test (RAST), skin tests (prick and intracutaneous), and oral challenge with PcV. LTT was also performed in 20 control subjects exposed to PcV therapeutically, and in eight subjects with occupational exposure to this penicillin.
Nine patients had a positive in vivo test to PcV (five by oral challenge, three by intracutaneous test, and one by both tests), and six were challenge-negative. When reactive PcV was used as antigen in LTT, positive LTT responses were observed in five of the nine patients with a positive in vivo test, and two of them were also side-chain specific. Positive LTT responses with reactive PcV also correlated with a positive RAST in five of seven subjects. None of the six patients with a negative challenge test, and only one of the 28 controls showed a positive LTT result with reactive PcV. Thus, the specificity of LTT with reactive PcV was 96%. In contrast, when PLL-conjugated PcV served as antigen, four challenge-negative subjects and 11 controls were LTT-positive.
The results of this study indicate that LTT with chemically reactive PcV could be useful as an in vitro complement in the diagnosis of PcV allergy and as a tool to reveal the side-chain specificity of peripheral blood lymphocytes. A positive LTT to PLL-conjugated PcV may be an indicator of immunization, but not necessarily allergy, to the penicilloyl structure.
本研究旨在探讨体外淋巴细胞增殖在苯氧甲基青霉素(PcV)过敏诊断中的应用,将以未结合形式添加到细胞培养物中的化学反应性PcV与作为抗原的PcV-聚-L-赖氨酸(PLL)偶联物进行比较。用反应性苄青霉素(PcG)和巴卡西林研究淋巴细胞增殖反应的侧链特异性。
通过淋巴细胞转化试验(LTT)、放射变应原吸附试验(RAST)、皮肤试验(点刺和皮内试验)以及PcV口服激发试验,对17例有PcV治疗相关过敏反应病史的患者进行研究。还对20例接受PcV治疗的对照受试者以及8例职业性接触该青霉素的受试者进行了LTT。
9例患者对PcV体内试验呈阳性(5例通过口服激发试验,3例通过皮内试验,1例两种试验均呈阳性),6例激发试验阴性。当将反应性PcV用作LTT中的抗原时,9例体内试验阳性的患者中有5例LTT反应呈阳性,其中2例也具有侧链特异性。7例受试者中有5例反应性PcV的LTT阳性反应也与RAST阳性相关。6例激发试验阴性的患者中无一例,28例对照中只有1例对反应性PcV的LTT结果呈阳性。因此,反应性PcV的LTT特异性为96%。相比之下,当PLL偶联的PcV用作抗原时,4例激发试验阴性的受试者和11例对照LTT呈阳性。
本研究结果表明,化学反应性PcV的LTT可作为PcV过敏诊断的体外补充手段,以及揭示外周血淋巴细胞侧链特异性的工具。对PLL偶联的PcV的LTT阳性可能是对青霉素酰结构免疫而非过敏的指标。